Changes in psychiatric disorder incidence patterns during the COVID-19 pandemic in Korea: a study using the nationwide universal health insurance data.

Publication date: Dec 05, 2024

Few studies have evaluated the incidence of various psychiatric disorders during the coronavirus disease (COVID-19) pandemic using hospital visit data for the entire population of a nation. We used Korea’s universal compulsory health insurance data to conduct a descriptive analysis to evaluate changes in psychiatric disorder incidence during the COVID-19 pandemic. Hospital visit data related to psychiatric disorders were retrieved from the National Health Insurance Database. First-ever diagnosis for specific psychiatric disorders for each Korean was identified (from January 2015 to February 2023) and monthly age-standardized incidence rates were calculated. An interrupted time-series analysis was used to estimate counterfactual disease incidence rates and observed and counterfactual rates were compared using difference-in-difference framework. Compared to pre-pandemic period, there was a decrease in the incidence [percentage changes in monthly rate (95% confidence intervals)] of organic mental disorders [-14. 6% (-18. 4, -10. 9)] and psychoactive substance related disorders [-12. 9% (-17. 5, -8. 3)] during the pandemic. However, anxiety disorders [8. 8% (3. 1, 14. 6)], behavioral syndromes associated with physiological disturbances [8. 1% (4. 2, 11. 9)], mental retardation [8. 6% (3. 0, 14. 2)], psychological developmental disorders [19. 6% (11. 5, 27. 7)], childhood- and adolescent-onset behavioral and emotional disorders [45. 1% (28. 4, 61. 8)], and unspecified mental diseases [51. 8% (39. 8, 63. 8)] increased. Psychological disease incidence patterns changed substantially during the pandemic in South Korea. Various pandemic-related stressors, such as disrupted lifestyles and hospital accessibility, may have influenced these changes. The causes and public health consequences of these changes require further evaluation.

Open Access PDF

Concepts Keywords
Coronavirus Adolescent
Hospital Adult
Korean Aged
Psychoactive Child
COVID-19
COVID-19
Excess disease burden
Female
Humans
Incidence
Male
Mental Disorders
Middle Aged
Psychological disease
Republic of Korea
Universal Health Insurance
Young Adult

Semantics

Type Source Name
disease MESH psychiatric disorder
disease MESH COVID-19 pandemic
pathway KEGG Coronavirus disease
disease MESH organic mental disorders
disease MESH anxiety disorders
disease MESH syndromes
disease MESH mental retardation
disease MESH lifestyles
disease MESH causes
pathway REACTOME Reproduction
disease MESH infection
disease IDO country
drug DRUGBANK Ilex paraguariensis leaf
disease MESH death
drug DRUGBANK Fenamole
disease MESH delusional disorders
disease MESH mood disorders
disease MESH somatoform disorders
drug DRUGBANK Coenzyme M
disease MESH substance use
disease MESH Schizophrenia
drug DRUGBANK Trestolone
disease MESH anxiety
drug DRUGBANK Indoleacetic acid
disease MESH depression
disease MESH mental deterioration
disease MESH loneliness
disease MESH autism spectrum disorder
disease IDO production
disease IDO process
disease MESH facial expression
disease MESH depressive disorders
disease MESH dementia
disease MESH domestic violence
disease IDO intervention
disease MESH infectious diseases
disease IDO history
disease MESH emergency
disease MESH attempted suicide
disease MESH suicidal ideation
drug DRUGBANK Gold
drug DRUGBANK Serine
disease MESH respiratory diseases
disease MESH Bell’s palsy
disease MESH ischemic heart disease
disease MESH Cancer
disease MESH adolescent development
disease MESH uncertainty
disease MESH Autism
drug DRUGBANK Hydrocortisone
disease MESH suicides
drug DRUGBANK Methenamine
disease MESH Developmental disabilities

Original Article

(Visited 2 times, 1 visits today)